Abstract
Empowering role of nanoinformatics in design and elucidation of nanoparticles for effective cancer treatment has made this field a fascinating area for researchers, inspiring them to enhance up the quality and efficacy of existing anticancer medicines. Theoretical and computational modeling is being seen as a forefront solution for problems related to surface chemistry, optimized geometry, or other properties in nanoparticle designing and drug delivery. The current review aims to acquaint with the insight story of the incubation of in silico tools and techniques in nanotechnology to develop better anticancer nanomedicines. The review also recapitulates the assets and liabilities of this field and present an outline of existing inventiveness and endeavors of nanoinformatics. We propose how nanoinformatics could hasten up the advancements in anticancer nanomedicines through use of computational tools, nanoparticles repositories & various modeling and simulation methods.
Similar content being viewed by others
References
Ahmad J, Akhter S, Rizwanullah M et al (2015a) Nanotechnology-based inhalation treatments for lung cancer: state of the art. Nanotechnol Sci Appl 8:55
Ahmad J, Amin S, Rahman M, Rub R, Singhal M, Ahmad M, Rahman Z, Addo R, Ahmad F, Mushtaq G, Kamal M, Akhter S (2015b) Solid matrix based lipidic nanoparticles in oral cancer chemotherapy: applications and pharmacokinetics. Curr Drug Metab 16:633–644
Ahmad J, Akhter S, Greig NH et al (2016) Engineered nanoparticles against MDR in Cancer: the state of the art and its prospective. Curr Pharm Des 22:4360–4373
Akhtar S, Al-Sagair OA, Arif JM (2011) Novel aglycones of steroidal glycoalkaloids as potent tyrosine kinase inhibitors: role in VEGF and EGF receptors targeted angiogenesis. Lett Drug Des Discov 8:205–215
Ali I (2011) Nano anti-cancer drugs: pros and cons and future perspectives. Curr Cancer Drug Targets 11:131–134
Ali A, Ahmed Sheikh I, Mirza Z et al (2015) Application of proteomic tools in modern nanotechnological approaches towards effective management of neurodegenerative disorders. Curr Drug Metab 16:376–388
Appel N, Rückerl S, Langer M (2016) Nanolink: a robust and efficient protocol for small satellite radio links. In: 4S symposium: small satellites, systems and services proceedings. Valletta, pp 1–10
Aziz ZA b A, Ahmad A, Mohd-Setapar SH et al (2017) Recent advances in drug delivery of polymeric nano-micelles. Curr Drug Metab 18:16–29
Bae YH, Park K (2011) Targeted drug delivery to tumors: myths, reality and possibility. J Control Release 153:198–205
Bae KH, Chung HJ, Park TG (2011) Nanomaterials for cancer therapy and imaging. Mol Cell 31:295–302
Baker NA (2010) NIH cancer biomedical informatics grid (caBIG®) ICR nanotechnology working group. In: Nanoinformatics 2010, November 3 – 5, Arlington, VA
Bañares MA, Haase A, Tran L, Lobaskin V, Oberdörster G, Rallo R, Leszczynski J, Hoet P, Korenstein R, Hardy B, Puzyn T (2017) CompNanoTox2015: novel perspectives from a European conference on computational nanotoxicology on predictive nanotoxicology. Nanotoxicology 11:839–845
Bar-Zeev M, Livney YD, Assaraf YG (2017) Targeted nanomedicine for cancer therapeutics: towards precision medicine overcoming drug resistance. Drug Resist Updat 31:15–30
Berger M (2014) An all-carbon optical diode for photonic computing available at www.nanowerk.com posted on Sep 01, 2014
Bhutani H, Kurmi M, Singh S, Beg S, Singh B (2014) Quality by design (QbD) in analytical sciences: an overview. Pharma Times 46(8):71–75
Cai W, Chen X (2007) Nanoplatforms for targeted molecular imaging in living subjects. Small 3:1840–1854
Chandolu V, Dass CR (2013) Treatment of lung cancer using nanoparticle drug delivery systems. Curr Drug Discov Technol 10:170–176
Chavali AK, D’Auria KM, Hewlett EL, Pearson RD, Papin JA (2012) A metabolic network approach for the identification and prioritization of antimicrobial drug targets. Trends Microbiol 20:113–123
Crist RM, Grossman JH, Patri AK, Stern ST, Dobrovolskaia MA, Adiseshaiah PP, Clogston JD, McNeil SE (2013) Common pitfalls in nanotechnology: lessons learned from NCI’s nanotechnology characterization laboratory. Integr Biol 5:66–73
Dang Y, Zhang Y, Chen H, Brown SA, Hu PJH, Nunamaker JF (2012) Theory-informed design and evaluation of an advanced search and knowledge mapping system in nanotechnology. J Manag Inf Syst 28:99–128
Davis ME, Shin DM (2008) Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 7:771–782
Day ES, Morton JG, West JL (2009) Nanoparticles for thermal cancer therapy. J Biomech Eng 131:74001
De la Iglesia D, Maojo V, Chiesa S et al (2011) International efforts in nanoinformatics research applied to nanomedicine. Methods Inf Med 50:84–95
De la Iglesia D, Cachau RE, García-Remesal M, Maojo V (2013) Nanoinformatics knowledge infrastructures: bringing efficient information management to nanomedical research. Comput Sci Discov 6:14011
van der Kamp MW, Mulholland AJ (2013) Combined quantum mechanics/molecular mechanics (QM/MM) methods in computational enzymology. Biochemistry 52:2708–2728
Diao Y-Y, Li H-Y, Fu Y-H et al (2011) Doxorubicin-loaded PEG-PCL copolymer micelles enhance cytotoxicity and intracellular accumulation of doxorubicin in adriamycin-resistant tumor cells. Int J Nanomedicine 6:1955
Dimakis N (2012) Computational nanoscience: applications for molecules, clusters, and solids, by Kálmán Varga and Joseph a. Driscoll. Scope: review. Level: advanced undergraduates and graduate students in computational physics, material science, and engineering. Contemporary Physics 53(2):183–184
Ding H, Ma Y (2016) Design strategy of surface decoration for efficient delivery of nanoparticles by computer simulation. Sci Rep 6:26783
Duncan GA, Bevan MA (2015) Computational design of nanoparticle drug delivery systems for selective targeting. Nanoscale 7:15332–15340
Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029
Erkimbaev AO, Zitserman VY, Kobzev GA, Trakhtengerts MS (2016) Nanoinformatics: problems, methods, and technologies. Sci Tech Inf Process 43:199–216
Folkman J (2008) Tumor angiogenesis: from bench to bedside. In: Marmé D, Fusenig N (eds) Tumor angiogenesis. Springer, Berlin, Heidelberg
Fullstone G, Wood J, Holcombe M, Battaglia G (2015) Modelling the transport of nanoparticles under blood flow using an agent-based approach. Sci Rep 5:10649
Gaheen S, Hinkal GW, Morris SA et al (2013) caNanoLab: data sharing to expedite the use of nanotechnology in biomedicine. Comput Sci Discov 6:14010
Gajewicz A, Cronin MTD, Rasulev B et al (2014) Novel approach for efficient predictions properties of large pool of nanomaterials based on limited set of species: nano-read-across. Nanotechnology 26:15701
Gao H, Shi W, Freund LB (2005) Mechanics of receptor-mediated endocytosis. Proc Natl Acad Sci U S A 102:9469–9474
Ghazani AA, Lee JA, Klostranec J, Xiang Q, Dacosta RS, Wilson BC, Tsao MS, Chan WC (2006) High throughput quantification of protein expression of cancer antigens in tissue microarray using quantum dot nanocrystals. Nano Lett 13(6(12)):2881–2886
Gonzalez-Ibanez AM, Gonzalez-Nilo F, Cachau R (2009) The collaboratory for structural nanobiology. Biophys J 96:49a
González-Nilo F, Pérez-Acle T, Guínez-Molinos S, Geraldo DA, Sandoval C, Yévenes A, Santos LS, Laurie VF, Mendoza H, Cachau RE (2011) Nanoinformatics: an emerging area of information technology at the intersection of bioinformatics, computational chemistry and nanobiotechnology. Biol Res 44:43–51
Grassi M, Grassi G (2005) Mathematical modelling and controlled drug delivery: matrix systems. Curr Drug Deliv 2:97–116
Gupta C, Prakash D, Gupta S (2017) Cancer treatment with nano-diamonds. Front Biosci 9:62–70
Hastings J, Jeliazkova N, Owen G, Tsiliki G, Munteanu CR, Steinbeck C, Willighagen E (2015) eNanoMapper: harnessing ontologies to enable data integration for nanomaterial risk assessment. J Biomed Semantics 6:10
Hull MS, Bowman D (2014) Nanotechnology environmental health and safety: risks, regulation, and management, 2nd edn. Elsevier Inc
Humod AT, Abed WNA-D (2012) Fuzzy-swarm controller for automatic voltage regulator of synchronous generator. Engineering and Technology Journal 30(3):454–473
Irish JM, Kotecha N, Nolan GP (2006) Mapping normal and cancer cell signalling networks: towards single-cell proteomics. Nat Rev Cancer 6:146–155
Ironi L, Tentoni S (2003) Model-based assessment of physicochemical properties of drug delivery materials. Comput Chem Eng 27(6):803–812
Jabir NR, Tabrez S, Ashraf GM et al (2012) Nanotechnology-based approaches in anticancer research. Int J Nanomedicine 7:4391
Klimeck G, McLennan M, Brophy SP, Adams III GB, Lundstrom MS (2008) Nanohub. Org: advancing education and research in nanotechnology. Comput Sci Eng 10:17–23
Kore PP, Mutha MM, Antre RV, Oswal RJ, Kshirsagar SS (2012) Computer-aided drug design: an innovative tool for modeling. Open J Med Chem 2:139–148
Lafourcade M, Joubert A, Le Brun N (2015) Games with a purpose (GWAPS). John Wiley & Sons, Inc.
Li Y, Stroberg W, Lee T-R, Kim HS, Man H, Ho D, Decuzzi P, Liu WK (2014) Multiscale modeling and uncertainty quantification in nanoparticle-mediated drug/gene delivery. Comput Mech 53:511–537
Li Y, Lian Y, Zhang LT, Aldousari SM, Hedia HS, Asiri SA, Liu WK (2016) Cell and nanoparticle transport in tumour microvasculature: the role of size, shape and surface functionality of nanoparticles. Interface Focus 6:20150086
Liu P, Kim B, Friesner RA, Berne BJ (2005) Replica exchange with solute tempering: a method for sampling biological systems in explicit water. Proc Natl Acad Sci U S A 102:13749–13754
Liu Y, Shah S, Tan J (2012) Computational modeling of nanoparticle targeted drug delivery. Rev Nanosci Nanotechnol 1:66–83
López-Alonso C, García-Cambero JP (2014) Informatic resources useful for the development of biomedical applications of nanomaterials and their toxicological evaluation. Rev Toxicol 31:23–30
Loverde SM, Klein ML, Discher DE (2012) Nanoparticle shape improves delivery: rational coarse grain molecular dynamics (rCG-MD) of Taxol in worm-like PEG-PCL micelles. Adv Mater 24:3823–3830
Lynch I, Salvati A, Dawson KA (2009) Protein-nanoparticle interactions: what does the cell see? Nat Nanotechnol 4:546–547
Maojo V, Martin-Sanchez F, Kulikowski C, Rodriguez-Paton A, Fritts M (2010) Nanoinformatics and DNA-based computing: catalyzing nanomedicine. Pediatr Res 67:481–489
Maojo V, Fritts M, de la Iglesia D et al (2012) Nanoinformatics: a new area of research in nanomedicine. Int J Nanomedicine 7:3867
McDougall SR, Anderson ARA, Chaplain MAJ, Sherratt JA (2002) Mathematical modelling of flow through vascular networks: implications for tumour-induced angiogenesis and chemotherapy strategies. Bull Math Biol 64:673–702
Melagraki G, Afantitis A (2014) Enalos InSilicoNano platform: an online decision support tool for the design and virtual screening of nanoparticles. RSC Adv 4:50713–50725
Nalwa H (1999) Handbook of nanostructured materials and nanotechnology, five-volume set. Academic Press
Nano4Me.Org. NACK educational resources. The Pennsylvania State University Accesed May 30, 2014
Neumann D, Lehr C-M, Lenhof H-P, Kohlbacher O (2004) Computational modeling of the sugar–lectin interaction. Adv Drug Deliv Rev 56:437–457
Nguyen KT (2011) Targeted nanoparticles for cancer therapy: promises and challenge. J Nanomedic Nanotechnol 2:103e. https://doi.org/10.4172/2157-7439.1000103e
Ok ZD, Benneyan JC, Isaacs JA (2009) Nanotechnology environmental, health, and safety issues: brief literature review since 2000. Ieee International Symposium on Sustainable Systems and Technology, Issst ’09 in Cooperation with 2009 Ieee International Symposium on Technology and Society, Istas. https://doi.org/10.1109/ISSST.2009.5156772
Orlandini S, Pinzauti S, Furlanetto S (2013) Application of quality by design to the development of analytical separation methods. Anal Bioanal Chem 405:443–450
Ostraat ML, Mills KC, Guzan KA, Murry D (2013) The nanomaterial registry: facilitating the sharing and analysis of data in the diverse nanomaterial community. Int J Nanomedicine 8:7
Ostrowski AD, Martin T, Conti J, Hurt I, Harthorn BH (2009) Nanotoxicology: characterizing the scientific literature, 2000–2007. J Nanopart Res 11:251–257
Petersen A, Anderson A, Allan S, Wilkinson C (2006) Nanotechnology in the news. Nanotechweb.org. Accessed 15 March 2018
Pyne S, Hu X, Wang K, Rossin E, Lin TI, Maier LM, Baecher-Allan C, McLachlan GJ, Tamayo P, Hafler DA, de Jager PL, Mesirov JP (2009) Automated high-dimensional flow cytometric data analysis. Proc Natl Acad Sci 106:8519–8524
Raffa V, Ciofani G, Vittorio O, Riggio C, Cuschieri A (2010) Physicochemical properties affecting cellular uptake of carbon nanotubes. Nanomedicine 5:89–97
Raies AB, Bajic VB (2016) In silico toxicology: computational methods for the prediction of chemical toxicity. Wiley Interdiscip Rev Comput Mol Sci 6:147–172
Rajeshwari A, Prathna TC, Balajee J et al (2013) Computational approach for particle size measurement of silver nanoparticle from electron microscopic image. Int J Pharm Pharm Sci 5:619
Reznik-Zellen R, Stevens B, Thorn M et al (2008) InterNano: e-Science for the nanomanufacturing community. In: eScience, 2008. eScience’08. IEEE fourth international conference on IEEE, pp 382–383
Roberts WG, Palade GE (1995) Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108:2369–2379
Ruenraroengsak P, Cook JM, Florence AT (2010) Nanosystem drug targeting: facing up to complex realities. J Control Release 141:265–276
Sarkar A, Fatima I, Mohammad Sajid Jamal Q, Sayeed U, Kalim A. Khan M, Akhtar S, Amjad Kamal M, Farooqui A, Haris Siddiqui M (2017a) Nanoparticles as a carrier system for drug delivery across blood brain barrier. Curr Drug Metab 18:129–137
Sarkar S, Osama K, Mohammad Sajid Jamal Q et al (2017b) Advances and implications in nanotechnology for lung cancer management. Curr Drug Metab 18:30–38
Schulte PA, Geraci CL, Zumwalde RD, Castranova V, Kuempel E, Methner MM, Hoover MD, Murashov V (2010) Nanotechnologies and nanomaterials in the occupational setting. J Occup Environ Hyg 1:63–68
Senger DR, Galli SJ, Dvorak AM et al (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219(80):983–985
Shi J, Kantoff PW, Wooster R, Farokhzad OC (2017) Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer 17:20–37
Shirsat AE, Chitlange SS (2015) QUALITY BY DESIGN APPROACH TO OPTIMIZATION OF TACROLIMUS LOADED PLGA NANOPARTICLES. Int J Pharm Sci Res 6:4342
Shityakov S, Roewer N, Broscheit J-A, Förster C (2017) In silico models for nanotoxicity evaluation and prediction at the blood-brain barrier level: a mini-review. Comput Toxicol 2:20–27
Singh J, Jaggi P, Kaur S (2016) Nano-medicine: promising drug for future in research and reviews. Journal of Pharmaceutics and Nanotechnology 4:14–22
Sykes EA, Dai Q, Sarsons CD, Chen J, Rocheleau JV, Hwang DM, Zheng G, Cramb DT, Rinker KD, Chan WCW (2016) Tailoring nanoparticle designs to target cancer based on tumor pathophysiology. Proc Natl Acad Sci 113:E1142–E1151
Tantra R, Oksel C, Puzyn T, Wang J, Robinson KN, Wang XZ, Ma CY, Wilkins T (2015) Nano (Q) SAR: challenges, pitfalls and perspectives. Nanotoxicology 9:636–642
Thomas DG, Pappu RV, Baker NA (2011) NanoParticle ontology for cancer nanotechnology research. J Biomed Inform 44:59–74
Thomas DG, Gaheen S, Harper SL, Fritts M, Klaessig F, Hahn-Dantona E, Paik D, Pan S, Stafford GA, Freund ET, Klemm JD, Baker NA (2013) ISA-TAB-Nano: a specification for sharing nanomaterial research data in spreadsheet-based format. BMC Biotechnol 13:2
Toxnet L (2006) Toxicology data network. Hazard Subst Data Bank (HSDB) United States Natl Libr Med data tabun http//toxnet.nlm.nih.gov/cgi-bin/sis/search/f. Accessed 25 March 2018
Ushaa SM, Eswaran V (2012) MODELING AND SIMULATION OF NANOSENSOR ARRAYS FOR AUTOMATED DISEASE DETECTION AND DRUG DELIVERY UNIT. Int J Adv Eng Technol 2:564
Voter AF, Montalenti F, Germann TC (2002) Extending the time scale in atomistic simulation of materials. Annu Rev Mater Res 32:321–346
Wang X, Yang L, Chen ZG, Shin DM (2008) Application of nanotechnology in cancer therapy and imaging. CA Cancer J Clin 58:97–110
Willighagen E (2015) NanoWiki (release 1). https://doi.org/10.6084/m9.figshare.1330208
Xia X-R, Monteiro-Riviere NA, Riviere JE (2010) An index for characterization of nanomaterials in biological systems. Nat Nanotechnol 5:671–675
Xu X, Khan MA, Burgess DJ (2011) A quality by design (QbD) case study on liposomes containing hydrophilic API: I. formulation, processing design and risk assessment. Int J Pharm 419:52–59
Yallapu MM, Ebeling MC, Jaggi M, Chauhan SC (2013) Plasma proteins interaction with curcumin nanoparticles: implications in cancer therapeutics. Curr Drug Metab 14:504–515
Yerlikaya F, Ozgen A, Vural I, Guven O, Karaagaoglu E, Khan MA, Capan Y (2013) Development and evaluation of paclitaxel nanoparticles using a quality-by-design approach. J Pharm Sci 102:3748–3761
Yezhelyev MV, Al-Hajj A, Morris C, Marcus AI, Liu T, Lewis M, Cohen C, Zrazhevskiy P, Simons JW, Rogatko A, Nie S (2007) In situ molecular profiling of breast cancer biomarkers with multicolor quantum dots. Adv Mater 19(20):3146–3151
Yin PT, Shah S, Chhowalla M, Lee K-B (2015) Design, synthesis, and characterization of graphene–nanoparticle hybrid materials for bioapplications. Chem Rev 115:2483–2531
Yingling YG, Shapiro BA (2007) Computational design of an RNA hexagonal nanoring and an RNA nanotube. Nano Lett 7:2328–2334
Yu X, Trase I, Ren M, Duval K, Guo X, Chen Z (2016) Design of nanoparticle-based carriers for targeted drug delivery. J Nanomater. https://doi.org/10.1155/2016/1087250
Yuan F, Dellian M, Fukumura D et al (1995) Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 55:3752–3756
Yun Y-H, Eteshola E, Bhattacharya A, Dong Z, Shim JS, Conforti L, Kim D, Schulz M, Ahn C, Watts N (2009) Tiny medicine: nanomaterial-based biosensors. Sensors 9:9275–9299
Zhao S, Iyengar R (2012) Systems pharmacology: network analysis to identify multiscale mechanisms of drug action. Annu Rev Pharmacol Toxicol 52:505–521
Author information
Authors and Affiliations
Corresponding author
Additional information
Responsible editor: Philippe Garrigues
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sharma, N., Sharma, M., Sajid Jamal, Q.M. et al. Nanoinformatics and biomolecular nanomodeling: a novel move en route for effective cancer treatment. Environ Sci Pollut Res 27, 19127–19141 (2020). https://doi.org/10.1007/s11356-019-05152-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11356-019-05152-8